# Pharmacotherapy for insomnia in children and adolescents: a systematic review of clinical practice guidelines and expert recommendations - URL: https://alisanburak.com/en/wcp-2026-posterler/ev1264 - Language: en - Last updated: not specified - Page title: Pharmacotherapy for insomnia in children and adolescents: a systematic review of clinical practice guidelines and expert recommendations | WCP 2026 Summary > Recommendations for medications other than melatonin in pediatric insomnia are inconsistent across guidelines and, in some cases, contradictory. This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev1264) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV1264 E-PosterSleep and LifestyleSystematic review # Pharmacotherapy for insomnia in children and adolescents: a systematic review of clinical practice guidelines and expert recommendations PHARMACOTHERAPY OF INSOMNIA IN CHILDREN AND ADOLESCENTS — A SYSTEMATIC REVIEW OF CLINICAL PRACTICE GUIDELINES AND EXPERT RECOMMENDATIONS Presenter: Shian Ming Tan Country: Singapore Institution: Department of Psychiatry, Sengkang General Hospital Recommendations for medications other than melatonin in pediatric insomnia are inconsistent across guidelines and, in some cases, contradictory. The aim of this review is to summarize guideline and expert consensus recommendations on pharmacotherapy for insomnia in children and adolescents. PubMed was systematically searched for clinical guidelines and expert/consensus recommendations published through December 31, 2025, and documents containing pharmacological recommendations for children or adolescents were included. Eight documents were identified; three were excluded because they addressed only melatonin use and it was unclear whether they had evaluated other medications, and one was excluded because it did not recommend any medication. The analysis was conducted on the remaining four documents. Melatonin is the most frequently recommended medication, although dosing guidance varies: the American Academy of Neurology guideline recommends it when behavioral strategies are insufficient, the Chinese guideline conditionally recommends it under professional supervision, and the Spanish consensus document lists it as a first-line option. Other medications were each recommended in only one document: clonidine (particularly in the presence of comorbid ADHD/developmental delay), trazodone (in the presence of comorbid depression), mirtazapine, and gabapentin; first-generation antihistamines (diphenhydramine, hydroxyzine) were listed as second-line options, and iron supplementation was conditionally recommended. One document explicitly recommends against benzodiazepines, Z-drugs, and antipsychotics, while another does not support routine pharmacotherapy other than melatonin. The authors note contradictions between documents regarding medications other than melatonin and highlight the need for further empirical studies and harmonization of guideline recommendations. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1290) How to cite this study APA 7: Tan, S. M., et al. (2026, September 23-26). Pharmacotherapy of insomnia in children and adolescents — a systematic review of clinical practice guidelines and expert recommendations [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1290 Vancouver: Tan SM, et al. Pharmacotherapy of insomnia in children and adolescents — a systematic review of clinical practice guidelines and expert recommendations [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1290 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [Yaşam boyu DEHB'de kronotip](https://alisanburak.com/en/wcp-2026-posterler/ev0082) - [Erken ergenlerde psikopatolojik belirtiler ile uyku bozukluklarının birlikte görülmesi: boylamsal ağ analizleri](https://alisanburak.com/en/wcp-2026-posterler/ev0270) - [Fiziksel egzersiz ve ergenlerde uyku yeterliliği: fiziksel yorgunluk, boş zaman ekran süresi ve psikolojik sıkıntı üzerinden keşifsel seri aracılık analizi](https://alisanburak.com/en/wcp-2026-posterler/ev0277) - [Meyve tüketim biçimlerinin ruh sağlığı, enerji düzenlenmesi ve uyku kalitesiyle farklılaşan ilişkileri](https://alisanburak.com/en/wcp-2026-posterler/ev0581) - [Hadi hareket edelim: ruhsal hastalık tedavisinde spor ve egzersiz terapisinin fiziksel aktivite üzerindeki etkisi](https://alisanburak.com/en/wcp-2026-posterler/ev0582) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev1264 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim